Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 10/20 | 0.53 |
| ▸ | KYNU | Q16719 | 1/20 | 0.42 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.42 |
| ▸ | ACP3 | P15309 | 1/20 | 0.42 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5320092 | 0.86 | KYNU (0.50) | KIF11KYNUACP3 | |
| SCHEMBL5325671 | 0.84 | KIF11 (0.50) | KIF11 | |
| SCHEMBL15093694 | 0.80 | ACP3 (0.45) | ACP3 | |
| SCHEMBL5323354 | 0.78 | UGT2B7 (0.47) | KIF11 | |
| SCHEMBL27644152 | 0.78 | KYNU (0.48) | KIF11KYNUACP3 | |
| SCHEMBL5319551 | 0.76 | KYNU (0.49) | KIF11KYNUACP3 | |
| SCHEMBL9085971 | 0.76 | FFAR1 (0.50) | ACP3 | |
| SCHEMBL11706165 | 0.76 | ACP3 (0.47) | KIF11ACP3 | |
| SCHEMBL20922645 | 0.75 | TAAR1 (0.46) | KIF11ACP3 | |
| SCHEMBL10409370 | 0.75 | TRPA1 (0.46) | ACP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
| WO-2007113385-A1 | DIAGNOSTIC AND THERAPEUTIC AGENTS | KARYON-CTT LTD (FI) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | KIF11 1678/4885KYNU 1045/4885SLC1A5 3692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.